Lund, Sweden

Leif Ang Svensson

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Draco. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leif Ang Svensson. Retrieved from https://idiyas.com/inventor/leif-ang-svensson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leif Ang Svensson: Innovator in Therapeutically Active Compounds

Introduction

Leif Ang Svensson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmacology, particularly in the development of therapeutically active compounds. His work focuses on creating new bronchospasmolytically active compounds that exhibit long duration of action and reduced undesired side effects.

Latest Patents

Leif Ang Svensson holds a patent for therapeutically active compounds. This patent describes new bronchospasmolytically active compounds, which are characterized by a specific structural formula and therapeutically acceptable salts. The innovation aims to improve the efficacy and safety of treatments for bronchospasm.

Career Highlights

Throughout his career, Svensson has been associated with Aktiebolaget Draco, a company known for its advancements in pharmaceutical research. His work has contributed to the development of medications that enhance patient care and treatment outcomes.

Collaborations

Leif has collaborated with notable colleagues, including O A Olsson and Kjell I Wetterlin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Leif Ang Svensson's contributions to the field of therapeutically active compounds highlight his dedication to improving medical treatments. His innovative work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…